Abstract:Poisoning by household cleaners is the second most frequent cause of poisoning in the pediatric-age group after drug intake (Gummin DD, et al., Clin Toxicol (Phila) 2020; 58: 1360–1541). Degreasing agents are caustic substances whose components differ from each other (Hoffman RS, et al., N Engl J Med 2020; 382: 1739–1748) Serious, life-threatening poisonings should be treated in pediatric intensive care units (PICU), and sometimes rapid administration of extracorporeal treatments to remove toxins is required (Roberts DM, et al., Crit Care Med 2015; 43: 461–472). There is insufficient data in the literature on severe poisoning with degreasers. This report involves the successful treatment of an adolescent, who ingested large amounts of a degreaser to commit suicide. Ethical approval was obtained from the hospital and the patient's parents A previously healthy 15-year-old girl was admitted to the emergency department (ED) with complaints of nausea and vomiting. On arrival, the patient had paroxysmal limb movements, vertical nystagmus, and a metallic odor in her mouth. Blood gas values revealed pH:7.00, PCO 2 :69.3 mmHg, HCO 3 :16.9 mmol/L, and lactate:15 mmol/L. It was determined that she had taken approximately 350 ml [5% non-ionic active substance, cationic active substance, sodium salt of methylglycine-diacetic acid (MGDA)] from a household degreaser called Asperox 8 hours before the application. She was intubated due to respiratory arrest. Her airway was seen as edematous and hemorrhagic during intubation. Then she was transferred to PICU. Her Glasgow coma scale (GCS) was 5, with slow light reflexes, and paroxysmal limb tics lasting approximately 5 minutes each. Her blood pressure was 63/41 mmHg; on blood gas analysis: pH 6.86, PCO 2 27 mmHg, PO 2 94 mmHg, lactate 26.1 mmol/L, BE – 27.80, HCO 3 4.9 mmol/ L. A central venous catheter was placed, and epinephrine and norepinephrine infusions were administered. Low FiO2 (below 40%) was given when mechanically ventilated because there was endothelial damage due to the degreaser. The patient's ethanol level was normal, body fluids were tested for narcotics, and no harmful substances were detected. It was reported that she was healthy before ingesting degreaser and hadn't used high-protein binding meds, especially antidepressants. On the second day of admission, she developed multiple organ failure. Continuous venovenous hemodiafiltration (CVVHDF) was applied for fluid overload and to remove the toxins with a 4000 ml/1.73 m 2 /hr effluent dose. Plasma exchange (PE) was performed due to the development of thrombocytopenia-associated multi-organ failure. The initial dose of PE utilized plasma, with albumin being used in the following two sessions, each at 1.5 times the total plasma volume per session. Despite the decrease in creatinine after three days of PE and CVVHDF, she was still oliguric, her cardiac dysfunction persisted (high troponin level, ejection fraction 50% on echocardiography, high need for inotropic agents), and there was no neurological improvement without any sedation. Then we contacted the manufacturer's chemist again and learned that the active substance can be tightly bound to the plasma proteins. Therefore, we decided to apply hemoperfusion (HP). The hemoperfusion cartridge consisted of cellulose-coated activated carbon with a surface area of 150 milliliters, and the blood flow rate was started with a lower blood flow rate (150 ml/min) for the first half hour due to hypotension, then gradually increased to 200 ml/min. Subsequently, she underwent charcoal HP for approximately 4 hours in a single session. After HP, her hypotension resolved, inotropic infusions were reduced, and vasoactive inotrope score (VIS) decreased from 92 to 40 ([Table 1]). The patient's laboratory values are shown in [Table 2]. Eighteen hours after -Abstract Truncated-

Intermittent haemodialysis and sustained low-efficiency dialysis (SLED) for acute theophylline toxicity

Extracorporeal treatment for theophylline poisoning: Systematic review and recommendations from the EXTRIP workgroup

Overdose of methyldopa, indapamide and theophylline resulting in prolonged hypotension, marked diuresis and hypokalaemia in an elderly patient

Simultaneous Treatment of Two Severe Acute Intoxication and Acute Kidney Injury

Acute theophylline toxicity and the use of esmolol to reverse cardiovascular instability

A Rare Case of Hemodialysis as an Extracorporeal Treatment for Severe Phenytoin Overdose

Extracorporeal life support in severe drug intoxication: a retrospective cohort study of seventeen cases

Removal of common antimicrobial agents by sustained low-efficiency dialysis

Plasmapheresis In The Treatment Of Multi-Drug Intoxication Involving Levothyroxine Sodium And Calcium Channel Blockers: A Case Report

A Severe Degreaser Poisoning Treated Successfully with Extracorporeal Therapies in an Adolescent. When Should Charcoal Hemoperfusion Take Priority

Plasma exchange for the management of digoxin toxicity in an individual with an acute kidney injury: A case report

Successful Treatment of Severe Digitoxin Intoxication with CytoSorb® Hemoadsorption

Extracorporeal treatment for calcium channel blocker poisoning: systematic review and recommendations from the EXTRIP workgroup

Severe Clozapine Poisoning Treated by Extracorporeal Blood Purification Therapy

Lipid emulsion use precluding renal replacement therapy

Prolonged requirement for ventilatory support in a patient with Eskalith overdose.

Vancomycin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis

Extracorporeal treatment for ethylene glycol poisoning: systematic review and recommendations from the EXTRIP workgroup

Availability and cost of extracorporeal treatments for poisonings and other emergency indications: a worldwide survey

Inadvertent Intoxication with Salbutamol, Treated with Hemodialysis: A Case Report and Brief Review of the Literature

Antibiotic Dosing in Sustained Low-Efficiency Dialysis in Critically Ill Patients